tolbutamide has been researched along with antipyrine in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 23 (57.50) | 18.7374 |
1990's | 4 (10.00) | 18.2507 |
2000's | 5 (12.50) | 29.6817 |
2010's | 8 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Carrupt, PA; Martel, S; Ottaviani, G | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Conradi, R; Lee, PH; Shanmugasundaram, V | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bending, MR; Dollery, CT; Kahn, GC; Mucklow, JC | 1 |
Gachályi, B; Káldor, A; Szeberényi, S | 2 |
Adjepon-Yamoah, KK; Finlayson, ND; Forrest, JA; Prescott, LF | 1 |
Eichelbaum, M | 1 |
Reidenberg, MM | 2 |
Reidenberg, MM; Vesell, ES | 1 |
Daintith, H; O'Malley, K; Stevenson, IH | 1 |
Houston, JB; Matthew, DE | 1 |
Rieth, H; Sauerbrey, N | 1 |
Back, DJ; Mihaly, GW; Tjia, JF; Ward, SA | 1 |
Back, DJ; Mönig, H; Ohnhaus, EE; Park, BK; Tjia, J | 1 |
Hanano, M; Iga, T; Sawada, Y; Sugiyama, Y | 1 |
Welch, RM | 1 |
Ikeda, M; Imamura, T; Otsuji, H | 1 |
Andreasen, PB; Vesell, ES | 1 |
Andritsch, F; Gundert-Remy, U; Marquardt, R; Weber, E | 1 |
Burns, JJ; Harrison, YE; Welch, RM | 1 |
Dibbern, HW | 1 |
Gachályi, B; Káldor, A; Tornyossy, M; Vas, A | 1 |
Biltz, H; Pentz, R; Siegers, CP | 1 |
Goldberg, DM | 1 |
Krishna, DM; Krishnaiah, YS; Satyanarayana, S; Visweswaram, D | 1 |
Elliott, BD; Johnson, R; Langer, O; Prihoda, T; Schenker, S | 1 |
Back, DJ; Brockmann, B; Heidemann, HT; Mönig, H; Ohnhaus, EE; Schulte, HM | 1 |
GLOBUS, M; MCCOLL, JD; ROBINSON, S | 1 |
5 review(s) available for tolbutamide and antipyrine
Article | Year |
---|---|
Drug metabolism in liver disease.
Topics: Acetaminophen; Acute Disease; Antipyrine; Chemical and Drug Induced Liver Injury; Chronic Disease; Half-Life; Humans; Isoniazid; Lidocaine; Liver; Liver Diseases; Pharmaceutical Preparations; Tolbutamide | 1975 |
Drug metabolism in thyroid disease.
Topics: Administration, Oral; Aminopyrine; Anticoagulants; Antipyrine; Digitalis Glycosides; Hormones; Humans; Kinetics; Methimazole; Pharmaceutical Preparations; Propylthiouracil; Riboflavin; Steroids; Thyroid Diseases; Tolbutamide | 1976 |
Drug metabolism in uremia.
Topics: Acetohexamide; Animals; Antipyrine; Humans; Hydrolysis; Lipid Metabolism; Microsomes, Liver; Oxidation-Reduction; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Procainamide; Rats; Tolbutamide; Uremia; Vitamin D | 1975 |
Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.
Topics: Animals; Antipyrine; Barbiturates; Biological Availability; Chlorpromazine; Diazepam; Drug Evaluation; Female; Half-Life; Humans; Kinetics; Male; Metabolic Clearance Rate; Pentazocine; Pharmaceutical Preparations; Phenylbutazone; Phenytoin; Propranolol; Quinidine; Rats; Species Specificity; Tissue Distribution; Tolbutamide; Valproic Acid; Warfarin | 1985 |
The expanding role of microsomal enzyme induction, and its implications for clinical chemistry.
Topics: Acetaminophen; Alcoholism; Animals; Antipyrine; Aryl Hydrocarbon Hydroxylases; Electron Transport; Energy Intake; Enzyme Induction; Epilepsy; Female; Humans; Male; Microsomes, Liver; Pharmacology; Phenobarbital; Phenylbutazone; Phenytoin; Smoking; Tolbutamide; Warfarin | 1980 |
2 trial(s) available for tolbutamide and antipyrine
Article | Year |
---|---|
[Interaction studies with fluconazole, a new triazole antifungal drug].
Topics: Adult; Antipyrine; Cimetidine; Clinical Trials as Topic; Contraceptives, Oral; Cyclosporins; Double-Blind Method; Drug Interactions; Female; Fluconazole; Humans; Male; Testosterone; Tolbutamide; Warfarin | 1989 |
Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration.
Topics: Administration, Oral; Adult; Antipyrine; Clinical Trials as Topic; Female; Half-Life; Humans; Injections, Intravenous; Kinetics; Liver Cirrhosis; Male; Middle Aged; Solutions; Spectrophotometry, Ultraviolet; Time Factors; Tolbutamide; Warfarin | 1974 |
33 other study(ies) available for tolbutamide and antipyrine
Article | Year |
---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
Topics: Humans; Membranes, Artificial; Models, Biological; Models, Molecular; Octanols; Permeability; Pharmaceutical Preparations; Skin Absorption; Water | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay.
Topics: 1-Methyl-3-isobutylxanthine; Cell Line; Cell Membrane Permeability; Humans; Models, Biological; Quantitative Structure-Activity Relationship; Skin Absorption | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Drug concentration in saliva.
Topics: Adolescent; Adult; Aged; Antipyrine; Chlorpropamide; Humans; Hydrogen-Ion Concentration; Male; Meperidine; Middle Aged; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Propranolol; Protein Binding; Saliva; Tolbutamide | 1978 |
m-Trifluoromethyl-alpha-ethylbenzhydrol: a new enzyme inducer.
Topics: Adult; Animals; Antipyrine; Benzhydryl Compounds; Enzyme Induction; Female; Glucaric Acid; Half-Life; Humans; Male; Mice; Mice, Inbred Strains; Middle Aged; Rats; Rats, Inbred Strains; Species Specificity; Tolbutamide | 1978 |
[The effect of a new compound (m-trifluormethyl-alpha-ethylbenxhydrol) on the mixed oxygenase function system of the liver].
Topics: Animals; Antipyrine; Benzhydryl Compounds; Enzyme Induction; Humans; Liver; Mice; Oxygenases; Rats; Tolbutamide | 1979 |
Obesity and fasting--effects on drug metabolism and drug action in man.
Topics: Adult; Animals; Antipyrine; Atropine; Blood Proteins; Fasting; Female; Humans; Isoniazid; Obesity; Pharmaceutical Preparations; Procaine; Protein Binding; Sulfisoxazole; Tolbutamide | 1977 |
Unaltered metabolism of antipyrine and tolbutamide in fasting man.
Topics: Administration, Oral; Adult; Antipyrine; Fasting; Female; Half-Life; Humans; Injections, Intravenous; Male; Metabolic Clearance Rate; Obesity; Tolbutamide | 1975 |
Influence of diabetes mellitus on drug metabolism in man.
Topics: Antipyrine; Chlorpropamide; Diabetes Mellitus; Diet, Diabetic; Female; Half-Life; Humans; Insulin; Kinetics; Male; Middle Aged; Pharmaceutical Preparations; Tolbutamide | 1976 |
Drug metabolizing capacity in vitro and in vivo--II. Correlations between hepatic microsomal monooxygenase markers in phenobarbital-induced rats.
Topics: 7-Alkoxycoumarin O-Dealkylase; Animals; Antipyrine; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme System; Enzyme Induction; In Vitro Techniques; Male; Microsomes, Liver; Oxidoreductases; Phenobarbital; Rats; Rats, Inbred Strains; Theophylline; Tolbutamide | 1990 |
The effect of some benzimidazoles on the disposition of antipyrine and tolbutamide from the rat isolated perfused liver.
Topics: Animals; Antipyrine; Benzimidazoles; Drug Interactions; In Vitro Techniques; Liver; Male; Rats; Rats, Inbred Strains; Tolbutamide | 1985 |
Selective inhibition of drug oxidation after simultaneous administration of two probe drugs, antipyrine and tolbutamide.
Topics: Adult; Antipyrine; Cimetidine; Female; Half-Life; Humans; Male; Oxidation-Reduction; Pharmaceutical Preparations; Primaquine; Sulfaphenazole; Tolbutamide | 1988 |
Drug-protein binding: a method for studying the interactions of drugs with bishydroxycoumarin (dicoumarol) in dogs.
Topics: Allopurinol; Animals; Antipyrine; Blood Coagulation; Dicumarol; Dogs; Drug Interactions; Drug Synergism; Enzyme Induction; Half-Life; Liver; Methods; Oxidoreductases; Phenobarbital; Phenylbutazone; Protein Binding; Prothrombin Time; Time Factors; Tolbutamide | 1973 |
Comparative studies on hepatic N- and O-demethylation.
Topics: Aniline Compounds; Animals; Anisoles; Antipyrine; Benzene; Biotransformation; Depression, Chemical; Ethylamines; Female; Hydroxylation; Kinetics; Liver; Methylcholanthrene; Metyrapone; Microsomes, Liver; Phenobarbital; Proadifen; Pyridines; Rats; Stimulation, Chemical; Tolbutamide | 1972 |
[Induction of drug-catabolizing enzymes in chronic alcoholics].
Topics: Alcoholism; Antipyrine; Chronic Disease; Enzyme Induction; Humans; Microsomes, Liver; Pharmaceutical Preparations; Tolbutamide | 1974 |
Implications of enzyme induction in drug toxicity studies.
Topics: Animals; Antipyrine; Diphenhydramine; Dogs; Enzyme Induction; Female; Haplorhini; Liver; Male; Microsomes; Peptic Ulcer; Phenylbutazone; Probenecid; Rats; Tolbutamide | 1967 |
[On the resportion profile of drugs. 2. On studies with the resorption model].
Topics: Absorption; Antipyrine; Aspirin; Codeine; Hydrogen-Ion Concentration; Models, Biological; Phenacetin; Phenobarbital; Tolbutamide | 1966 |
Effect of alphamethyldopa on the half-lives of antipyrine, tolbutamide and D-glucaric acid excretion in man.
Topics: Adult; Antipyrine; Drug Interactions; Female; gamma-Glutamyltransferase; Glucaric Acid; Half-Life; Humans; Male; Methyldopa; Middle Aged; Sugar Acids; Tolbutamide | 1980 |
Effect of diethyldithiocarbamate on the metabolic elimination of hexobarbital, phenazone, tolbutamide and four halogenated hydrocarbons.
Topics: Animals; Antipyrine; Ditiocarb; Hexobarbital; Hydrocarbons, Halogenated; Kinetics; Male; Mice; Mixed Function Oxygenases; Thiocarbamates; Tolbutamide | 1981 |
Interaction of pargyline with tolbutamide in rabbits.
Topics: Animals; Antipyrine; Blood Glucose; Drug Interactions; Female; Half-Life; Hypoglycemia; Injections, Intraperitoneal; Male; Microsomes, Liver; Pargyline; Rabbits; Tolbutamide | 1995 |
Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer.
Topics: Administration, Oral; Analysis of Variance; Antipyrine; Biological Transport; Chlorpropamide; Chromatography, High Pressure Liquid; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Maternal-Fetal Exchange; Models, Biological; Molecular Weight; Placenta; Pregnancy; Regression Analysis; Tolbutamide | 1994 |
Effect of chlormethiazole on hepatic monooxygenases activity in vivo.
Topics: Antipyrine; Chlormethiazole; Half-Life; Humans; Liver; Male; Mixed Function Oxygenases; Tolbutamide | 1993 |
EFFECT OF SOME THERAPEUTIC AGENTS ON THE DEVELOPING RAT FETUS.
Topics: Abnormalities, Drug-Induced; Animals; Antipyrine; Aspirin; Chloral Hydrate; Dimenhydrinate; Female; Fetal Development; Fetus; Humans; Pathology; Pharmacology; Pregnancy; Pregnancy, Animal; Rats; Research; Thalidomide; Tolbutamide; Toxicology | 1965 |